Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Ulcerative Colitis Immunology Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ulcerative Colitis Immunology Drugsmarket, defines the market attractiveness level of Ulcerative Colitis Immunology Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ulcerative Colitis Immunology Drugs industry, describes the types of Ulcerative Colitis Immunology Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ulcerative Colitis Immunology Drugs market and the development prospects and opportunities of Ulcerative Colitis Immunology Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ulcerative Colitis Immunology Drugs market in Chapter 13.
By Player:
AbbVie Inc
AMGEN
ROCHE
Biogen
Bristol-Myers Squibb Company
Janssen Biotech, Inc
Pfizer Inc
UCBCares
Celltrion Healthcare
Genentech USA, Inc
By Type:
Adalimumab
Certolizumab Pegol
Tofacitinib
Etanercept
Golimumab
Abatacept
Infliximab
Others
By End-User:
Rheumatoid Arthritis
Crohn's Disease (CD)
Ankylosing Spondylitis (AS)
Psoriasis (Ps)
Ulcerative Colitis (UC)
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ulcerative Colitis Immunology Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ulcerative Colitis Immunology Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ulcerative Colitis Immunology Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ulcerative Colitis Immunology Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ulcerative Colitis Immunology Drugs Market Analysis and Outlook to 2022
-
7.1 Global Ulcerative Colitis Immunology Drugs Consumption (2017-2022)
-
7.2 United States Ulcerative Colitis Immunology Drugs Consumption (2017-2022)
-
7.3 Europe Ulcerative Colitis Immunology Drugs Consumption (2017-2022)
-
7.4 China Ulcerative Colitis Immunology Drugs Consumption (2017-2022)
-
7.5 Japan Ulcerative Colitis Immunology Drugs Consumption (2017-2022)
-
7.6 India Ulcerative Colitis Immunology Drugs Consumption (2017-2022)
-
7.7 South Korea Ulcerative Colitis Immunology Drugs Consumption (2017-2022)
8 Region and Country-wise Ulcerative Colitis Immunology Drugs Market Analysis and Outlook to 2028
-
8.1 Global Ulcerative Colitis Immunology Drugs Consumption Forecast (2022-2028)
-
8.2 United States Ulcerative Colitis Immunology Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Ulcerative Colitis Immunology Drugs Consumption Forecast (2022-2028)
-
8.4 China Ulcerative Colitis Immunology Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Ulcerative Colitis Immunology Drugs Consumption Forecast (2022-2028)
-
8.6 India Ulcerative Colitis Immunology Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Ulcerative Colitis Immunology Drugs Consumption Forecast (2022-2028)
9 Global Ulcerative Colitis Immunology Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Ulcerative Colitis Immunology Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Adalimumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Certolizumab Pegol Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Tofacitinib Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Etanercept Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Golimumab Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Abatacept Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Infliximab Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Ulcerative Colitis Immunology Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Crohn's Disease (CD) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ankylosing Spondylitis (AS) Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Psoriasis (Ps) Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Ulcerative Colitis (UC) Consumption and Growth Rate (2017-2022)
10 Global Ulcerative Colitis Immunology Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Ulcerative Colitis Immunology Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Certolizumab Pegol Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Tofacitinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Etanercept Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Golimumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Abatacept Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Infliximab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ulcerative Colitis Immunology Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Crohn's Disease (CD) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ankylosing Spondylitis (AS) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Psoriasis (Ps) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Ulcerative Colitis (UC) Consumption Forecast and Growth Rate (2022-2028)
11 Global Ulcerative Colitis Immunology Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ulcerative Colitis Immunology Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ulcerative Colitis Immunology Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ulcerative Colitis Immunology Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ulcerative Colitis Immunology Drugs Market Competitive Analysis
-
14.1 AbbVie Inc
-
14.1.1 AbbVie Inc Company Details
-
14.1.2 AbbVie Inc Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AbbVie Inc Ulcerative Colitis Immunology Drugs Product and Service
-
14.2 AMGEN
-
14.2.1 AMGEN Company Details
-
14.2.2 AMGEN Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AMGEN Ulcerative Colitis Immunology Drugs Product and Service
-
14.3 ROCHE
-
14.3.1 ROCHE Company Details
-
14.3.2 ROCHE Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 ROCHE Ulcerative Colitis Immunology Drugs Product and Service
-
14.4 Biogen
-
14.4.1 Biogen Company Details
-
14.4.2 Biogen Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biogen Ulcerative Colitis Immunology Drugs Product and Service
-
14.5 Bristol-Myers Squibb Company
-
14.5.1 Bristol-Myers Squibb Company Company Details
-
14.5.2 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Product and Service
-
14.6 Janssen Biotech, Inc
-
14.6.1 Janssen Biotech, Inc Company Details
-
14.6.2 Janssen Biotech, Inc Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Janssen Biotech, Inc Ulcerative Colitis Immunology Drugs Product and Service
-
14.7 Pfizer Inc
-
14.7.1 Pfizer Inc Company Details
-
14.7.2 Pfizer Inc Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Inc Ulcerative Colitis Immunology Drugs Product and Service
-
14.8 UCBCares
-
14.8.1 UCBCares Company Details
-
14.8.2 UCBCares Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 UCBCares Ulcerative Colitis Immunology Drugs Product and Service
-
14.9 Celltrion Healthcare
-
14.9.1 Celltrion Healthcare Company Details
-
14.9.2 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Product and Service
-
14.10 Genentech USA, Inc
-
14.10.1 Genentech USA, Inc Company Details
-
14.10.2 Genentech USA, Inc Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Genentech USA, Inc Ulcerative Colitis Immunology Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ulcerative Colitis Immunology Drugs
-
Figure Ulcerative Colitis Immunology Drugs Picture
-
Table Global Ulcerative Colitis Immunology Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ulcerative Colitis Immunology Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ulcerative Colitis Immunology Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ulcerative Colitis Immunology Drugs Consumption by Country (2017-2022)
-
Figure United States Ulcerative Colitis Immunology Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Ulcerative Colitis Immunology Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Ulcerative Colitis Immunology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Ulcerative Colitis Immunology Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Ulcerative Colitis Immunology Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ulcerative Colitis Immunology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Ulcerative Colitis Immunology Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Ulcerative Colitis Immunology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ulcerative Colitis Immunology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ulcerative Colitis Immunology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ulcerative Colitis Immunology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ulcerative Colitis Immunology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ulcerative Colitis Immunology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adalimumab Consumption and Growth Rate (2017-2022)
-
Figure Global Certolizumab Pegol Consumption and Growth Rate (2017-2022)
-
Figure Global Tofacitinib Consumption and Growth Rate (2017-2022)
-
Figure Global Etanercept Consumption and Growth Rate (2017-2022)
-
Figure Global Golimumab Consumption and Growth Rate (2017-2022)
-
Figure Global Abatacept Consumption and Growth Rate (2017-2022)
-
Figure Global Infliximab Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Crohn's Disease (CD) Consumption and Growth Rate (2017-2022)
-
Figure Global Ankylosing Spondylitis (AS) Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis (Ps) Consumption and Growth Rate (2017-2022)
-
Figure Global Ulcerative Colitis (UC) Consumption and Growth Rate (2017-2022)
-
Figure Global Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Certolizumab Pegol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tofacitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Etanercept Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Golimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Abatacept Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infliximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Crohn's Disease (CD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ankylosing Spondylitis (AS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis (Ps) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ulcerative Colitis (UC) Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ulcerative Colitis Immunology Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ulcerative Colitis Immunology Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Ulcerative Colitis Immunology Drugs Product and Service
-
Table AMGEN (Foundation Year, Company Profile and etc.)
-
Table AMGEN Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AMGEN Ulcerative Colitis Immunology Drugs Product and Service
-
Table ROCHE (Foundation Year, Company Profile and etc.)
-
Table ROCHE Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ROCHE Ulcerative Colitis Immunology Drugs Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Ulcerative Colitis Immunology Drugs Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Product and Service
-
Table Janssen Biotech, Inc (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech, Inc Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech, Inc Ulcerative Colitis Immunology Drugs Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Ulcerative Colitis Immunology Drugs Product and Service
-
Table UCBCares (Foundation Year, Company Profile and etc.)
-
Table UCBCares Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCBCares Ulcerative Colitis Immunology Drugs Product and Service
-
Table Celltrion Healthcare (Foundation Year, Company Profile and etc.)
-
Table Celltrion Healthcare Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Healthcare Ulcerative Colitis Immunology Drugs Product and Service
-
Table Genentech USA, Inc (Foundation Year, Company Profile and etc.)
-
Table Genentech USA, Inc Ulcerative Colitis Immunology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech USA, Inc Ulcerative Colitis Immunology Drugs Product and Service
-
